Pfizer
PFE
PFE
2,962 hedge funds and large institutions have $99.7B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 367 funds opening new positions, 926 increasing their positions, 1,457 reducing their positions, and 245 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $106B → $99.7B (-$6.24B)
15% less call options, than puts
Call options by funds: $3.27B | Put options by funds: $3.87B
36% less repeat investments, than reductions
Existing positions increased: 926 | Existing positions reduced: 1,457
Holders
2,962
Holding in Top 10
41
Calls
$3.27B
Puts
$3.87B
Top Buyers
| 1 | +$672M | |
| 2 | +$418M | |
| 3 | +$408M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$181M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$144M |
Top Sellers
| 1 | -$630M | |
| 2 | -$330M | |
| 3 | -$290M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$279M |
| 5 |
Barclays
London,
United Kingdom
|
-$271M |